Fennec Pharmaceuticals (FENC) Return on Sales [ROS] (2020 - 2026)
Fennec Pharmaceuticals (FENC) recorded Return on Sales [ROS] of 9.72% in Q2 2026, up 38.02 percentage points from -28.31% a year earlier.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
On a TTM basis, Fennec Pharmaceuticals' Return on Sales [ROS] came in at -6.95% as of Jun 30, 2026, up 22.10 percentage points year-over-year; for FY2025, it was -14.07%, down 19.47 percentage points from FY2024.
- Annual Return on Sales [ROS] has a five-year change of +8928.43 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at 5.40% in FY2024 (+65.50 pp), -60.09% in FY2023 (+1216.84 pp) and -1276.94% in FY2022.
- The Q2 2026 figure is the highest quarterly Return on Sales [ROS] since Q1 2024.
- On a year-over-year basis, Return on Sales [ROS] rose in four of the last seven quarters, with an average year-over-year change of +4.28 percentage points.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 368.41 percentage points in Q1 2024, against a drop of 63.39 percentage points in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Fennec Pharmaceuticals | 357.35 Mn | 238.66 Mn | 17.15 Mn | 9.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.72% |
| Dec 31, 2025 | -18.54% |
| Sep 30, 2025 | -1.52% |
| Jun 30, 2025 | -28.31% |
| Mar 31, 2025 | -9.23% |
| Dec 31, 2024 | -11.79% |
| Sep 30, 2024 | -74.59% |
| Jun 30, 2024 | -69.39% |
| Mar 31, 2024 | 54.16% |
| Dec 31, 2023 | -18.67% |
| Sep 30, 2023 | -15.61% |
| Jun 30, 2023 | -140.33% |
| Mar 31, 2023 | -314.25% |
| Mar 31, 2021 | -9,486.50% |
| Dec 31, 2020 | -1,673.00% |
API Access
Fennec Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=FENC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "FENC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=FENC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();